Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.
Arthritis Care Res (Hoboken)
; 70(4): 608-616, 2018 04.
Article
in En
| MEDLINE
| ID: mdl-28575536
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Patients
/
Spondylitis, Ankylosing
/
Biological Products
/
Patient Acceptance of Health Care
/
Drug Costs
/
Health Expenditures
/
Financing, Personal
/
Infliximab
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Arthritis Care Res (Hoboken)
Journal subject:
REUMATOLOGIA
Year:
2018
Document type:
Article
Affiliation country:
Países Bajos
Country of publication:
Estados Unidos